Chemofit 250 mg Tablet
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Chemofit 250 mg Tablet

Chemofit 250 mg Tablet

Chemofit 250 mg Tablet contains gefitinib 250 mg, an oral targeted anticancer medicine. It is used for the treatment of non-small cell lung cancer (NSCLC). The tablet is taken by mouth according to the treatment regimen prescribed by a healthcare professional.

BUY NOW

Category

Gefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor that blocks signaling involved in the growth and survival of certain cancer cells. Chemofit 250 mg is specifically listed for NSCLC and is manufactured by RPG Life Sciences Ltd. Each tablet contains gefitinib 250 mg, with a documented pack presentation of 10 tablets. The medicine should be used only under appropriate medical supervision and according to the prescribed dosage.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 tablets
Manufacturer RPG Life Sciences Ltd

Product Also Known As

Chemofit 250 mg Tablet, Chemofit 250 Tablet, Chemofit 250 mg, Chemofit Gefitinib Tablet, Gefitinib 250 mg Tablet, Gefitinib 250 mg